ThromboGenics
Advancing Science. Enhancing Vision.
February 2, 2012 ThromboGenics Announces that the FDA Intends to Grant Ocriplasmin Priority Review… more »
January 5, 2012 ThromboGenics Publishes Financial Calender 2012… more »
